IL2 and COVID-19: The lower IL2-AIS score in this group of recovered patients, but not between disease severity groups in the hospitalised patients (Fig. 1C), indicates that the induction of the IL2-AIS is not directly associated with the severity of the COVID-19 symptoms during the acute phase of the disease and is therefore not merely the reflection of an increased pro-inflammatory state during the acute phase of the disease.